UBS Group AG

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1610520 ZURICH, V8

Back to VNDA Full portfolio

Position in VNDA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,855,527

+$78,484 QoQ

Shares Held

303,191

+17.9% QoQ

Ownership

0.501%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#28

of 172 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Common Shares in VNDA Over Time

Shares Held

Position Value (USD)

Derivatives in VNDA

reported options exposure · as of Dec 31, 2025

CallValue

$3,528

CallShares

400

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,747,178,871 across 561 Biotechnology names. VNDA ranks #215 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	5,450,825	$1,020,369,609
2	ROIV	Roivant Sciences Ltd.	17,466,641	$618,144,423
3	PTGX	Protagonist Therapeutics, Inc	3,399,221	$416,676,508
4	VRTX	Vertex Pharmaceuticals Inc / Ma	712,259	$353,800,411
5	MRNA	Moderna, Inc.	4,463,211	$312,558,664
6	INSM	INSMED Inc	2,584,446	$275,553,630
7	ABVX	Abivax S.A.	1,844,918	$245,853,771
8	MDGL	Madrigal Pharmaceuticals, Inc.	401,708	$215,697,109

All Filings in VNDA

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,855,527	303,191	+17.9%	Shares	Defined	2026-08-13
2026-03-31	$1,777,043	257,170	+106.3%	Shares	Defined	2026-05-05
2025-12-31	$3,528	400	-99.4%	Call	Defined	2026-01-29
2025-12-31	$1,099,545	124,665	-1.2%	Shares	Defined	2026-01-29
2025-09-30	$629,318	126,116	+80.6%	Shares	Defined	2025-11-13
2025-06-30	$329,663	69,844	-20.3%	Shares	Defined	2025-08-14
2025-03-31	$402,019	87,586	-61.9%	Shares	Defined	2025-05-13
2024-12-31	$1,101,398	229,937	+164.7%	Shares	Defined	2025-02-14
2024-09-30	$299,222	63,800	—	Call	Defined	2024-11-14
2024-09-30	$407,471	86,881	+10.8%	Shares	Defined	2024-11-14
2024-06-30	$443,016	78,410	+18.1%	Shares	Defined	2024-08-14
2024-03-31	$272,895	66,398	-12.2%	Shares	Defined	2024-05-13
2023-12-31	$319,078	75,611	-18.0%	Shares	Defined	2024-02-09
2023-09-30	$398,243	92,186	-30.0%	Shares	Defined	2023-11-09
2023-06-30	$867,935	131,705	-1.6%	Shares	Defined	2023-08-11
2023-03-31	$909,255	133,911	-3.6%	Shares	Defined	2023-05-12
2022-12-31	$1,026,455	138,898	+195.5%	Shares	Defined	2023-02-08
2022-09-30	$464,388	47,003	-18.6%	Shares	Defined	2022-11-10
2022-06-30	$629,397	57,743	-56.4%	Shares	Defined	2022-08-10
2022-03-31	$1,498,415	132,486	+141.3%	Shares	Defined	2022-05-16
2021-12-31	$861,506	54,908	+10.6%	Shares	Defined	2022-02-14
2021-09-30	$850,554	49,624	+1737.2%	Shares	Defined	2021-11-15
2021-06-30 ALXN	—	451,615	+40.4%	Shares	Defined	2021-08-13
2021-06-30	$58,098	2,701	-96.3%	Shares	Defined	2021-08-13
2021-03-31 ALXN	—	321,639	+178.4%	Shares	Defined	2021-05-12
2021-03-31	$1,107,935	73,764	+14.4%	Shares	Defined	2021-05-12
2020-12-31 ALXN	—	116,200	-7.9%	Put	Defined	2021-02-11
2020-12-31 ALXN	—	115,546	-86.8%	Shares	Defined	2021-02-11
2020-12-31	$847,398	64,490	+537.8%	Shares	Defined	2021-02-11
2020-09-30 ALXN	—	875,531	+90.9%	Shares	Defined	2020-11-12
2020-09-30 ALXN	—	126,200	0.0%	Put	Defined	2020-11-12
2020-09-30	$97,672	10,111	-60.9%	Shares	Defined	2020-11-12
2020-06-30 ALXN	—	458,642	-31.1%	Shares	Defined	2020-07-31
2020-06-30 ALXN	—	126,200	-9.7%	Put	Defined	2020-07-31
2020-06-30	$295,826	25,859	+912.1%	Shares	Defined	2020-07-31
2020-03-31 ALXN	—	665,755	—	Shares	Defined	2020-05-01
2020-03-31 ALXN	—	139,800	—	Put	Defined	2020-05-01
2020-03-31	$26,469	2,555	—	Shares	Defined	2020-05-01
No filing history on record for this holder in this stock.